← Back to Clinical Trials
Recruiting NCT05779761

NCT05779761 Brief Interventions for Coping with Distress

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05779761
Status Recruiting
Phase
Sponsor Teachers College, Columbia University
Condition Distress, Emotional
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2023-05-12
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Online, Self-Directed Attention Skills Training with Coaching SupportOnline, Self-Directed Attention & Reflective Thought Skills Training with Coaching SupportOnline, Self-Directed Health & Wellness Education Training with Coaching Support

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 180 participants in total. It began in 2023-05-12 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is being done to compare the effectiveness of three different skills trainings to cope with distress. These three trainings are: 1) an attention skills training, 2) an attention and reflective thought skills training, and 3) a health and wellness education training.

Eligibility Criteria

Inclusion Criteria: * Between the ages of 18 and 65 * Fluent in English (and therefore able to provide consent) * Currently living in New York City * Access to a smartphone and the internet * High self-reported worry, rumination, and/or self-criticism * Meet Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) criteria for at least one, current psychological disorder Exclusion Criteria: * Active suicidal ideation or intent * Substance dependence disorder, schizophrenia, bipolar-I disorder, or a primary DSM-5 diagnosis of borderline or narcissistic personality disorder * Individuals currently receiving therapy or psychosocial treatment who do not plan to continue with the same treatment throughout the study period * Individuals taking psychotropic mediation that has not been stabilized for a period of at least 3 months * Current students at Teachers College, Columbia University * Individuals with cardiac conditions, diagnosed hyperhidrosis, and traumatic brain injuries or other neurological conditions (e.g., dementia, Parkinson's, epilepsy)

Contact & Investigator

Central Contact

Douglas S Mennin, PhD

✉ mennin@tc.columbia.edu

📞 212-678-6609

Principal Investigator

Douglas S Mennin, PhD

PRINCIPAL INVESTIGATOR

Teachers College, Columbia University

Frequently Asked Questions

Who can join the NCT05779761 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Distress, Emotional. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05779761 currently recruiting?

Yes, NCT05779761 is actively recruiting participants. Contact the research team at mennin@tc.columbia.edu for enrollment information.

Where is the NCT05779761 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT05779761 clinical trial?

NCT05779761 is sponsored by Teachers College, Columbia University. The principal investigator is Douglas S Mennin, PhD at Teachers College, Columbia University. The trial plans to enroll 180 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology